Reuters logo
in 2 months
BRIEF-U.S. FDA says expanded approved use of Subcutaneous Actemra to treat adults with Giant Cell Arteritis
May 22, 2017 / 2:55 PM / in 2 months

BRIEF-U.S. FDA says expanded approved use of Subcutaneous Actemra to treat adults with Giant Cell Arteritis

1 Min Read

May 22 (Reuters) - U.S. FDA:

* U.S. FDA says expanded the approved use of Subcutaneous Actemra (Tocilizumab) to treat adults with Giant Cell Arteritis

* U.S. FDA says the FDA granted the supplemental approval of Actemra to Hoffman La Roche Inc Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below